CYTR Stock Price, News & Analysis
Company Description
CYTR (OTC: CYTR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.1M.
CYTR stock has declined 81.8% over the past year.
This page provides a comprehensive overview of CYTR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CYTR (CYTR) stock. Over the past 12 months, the stock has lost 81.8%. At a market capitalization of $4.1M, CYTR is classified as a micro-cap stock with approximately 45.0M shares outstanding.
Latest News
CYTR has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, partnership. View all CYTR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CYTR Company Profile & Sector Positioning
CYTR (CYTR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CYTR often look at related companies in the same sector, including Azitra Inc (AZTR), CNS Pharmaceuticals (CNSP), (KALTF), Xortx Therapeutics Inc (XRTX), and THERIVA BIOLOGICS INC (TOVX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CYTR's relative position within its industry.